Interim Subgroup Analysis For Response By Pd-L1 Status Of Classical-Lung, A Phase Ib/Ii Study Of Pepinemab (Vx15/2503) In Combination With Avelumab In Advanced Nsclc.
JOURNAL OF CLINICAL ONCOLOGY(2020)
Abstract
3011Background: Antibody blockade of semaphorin 4D (SEMA4D, CD100) promotes tumoral dendritic cell and CD8+ T cell infiltration and reduces function and recruitment of immunosuppressive myeloid cel...
MoreTranslated text
Key words
pepinemab,interim subgroup analysis,advanced nsclc,classical-lung
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined